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Abstract 
LDL oxidation within the arterial wall may contribute to the disease of atherosclerosis. There is some evidence that elevated plasma levels of copper 
are associated with an increased risk of coronary artery disease. We have investigated the conditions under which caeruloplasmin (the plasma copper 
carrier protein) can catalyse the macrophage-mediated modification of LDL. LOW concentrations of C&O, (< 1 PM) could catalyse the macrophage- 
mediated modification of LDL. Native caeruloplasmin was unable to catalyse the modification of LDL at pH 7.4, but could do so after preincubation 
at acidic pH. After preincubation at acidic pH, concentrations of caeruloplasmin as low as 30 pg/ml (about one-tenth of the human plasma level) 
could catalyse significant LDL oxidation when added to macrophages. The activation of copper in caeruloplasmin i  atherosclerotic lesions due to 
a localised acidic pH may help to explain why LDL oxidation occurs in these areas of the body. 
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1. Introduction 
The oxidation of low-density lipoprotein (LDL) in the 
arterial wall resulting in its rapid uptake by macrophages 
and their conversion into foam cells, the migration of 
monocytes into the arterial wall, cytotoxicity and many 
other effects may play an important role in the patho- 
genesis of atherosclerosis [ 11. 
Caeruloplasmin has been recognised as the major cop- 
per-containing component of mammalian plasma since 
its isolation in 1947. Over 90% of the copper in plasma 
is generally believed to be present as an integral part of 
this protein. It is a glycoprotein of relative molecular 
mass 132,000 which contains 6 or 7 copper atoms per 
molecule [22]. Two of the copper sites are occupied by 
paramagnetic type-1 copper atoms which endow the pro- 
tein with its characteristic blue colour. The remaining 
coppers are paramagnetic type-II and diamagnetic type- 
III coppers [3]. These copper atoms are nondialysable [4] 
and nonexchangeable with copper atoms in serum [5]. 
The oxidation of lipoproteins in extracellular fluids dur- 
ing storage may possibly be due to caeruloplasmin pro- 
moting their oxidation [6]. 
angina possessed higher levels than those with stable 
angina [7]. Caeruloplasmin is an acute phase protein and 
the increased levels may possibly be due to the stress 
produced by angina or myocardial infarction [8]. In a 
recent prospective study in Finnish men, however, an 
elevated serum copper level was found to correlate to an 
increased progression of carotid atherosclerotic lesions 
[9]. In addition, an association between high serum cop- 
per levels and cardiovascular mortality was shown in a 
prospective case-control study in Dutch men [lo]. An- 
other recent study has shown that high serum caeru- 
loplasmin levels correlate with an increased future risk 
of myocardial infarction [l 11. Another study in Finnish 
men found an association between high copper content 
in drinking water and high coronary heart disease mor- 
tality [ 121. 
We have investigated the ability of caeruloplasmin, of 
which plasma levels can apparently be a risk factor for 
coronary artery disease, to express catalytically active 
copper ions that can catalyse macrophage-mediated 
LDL modification. 
A recent study in Indian men reported that those with 
coronary artery disease had 44% higher levels of caeru- 
loplasmin than the controls, and that those with unstable 
2. Materials and methods 
*Corresponding author. Fax: (44) (734) 310 180. 
2.1. Isolation and radioiodination of LDL 
LDL (1.019-1.063 g/ml) was isolated from normal pooled human 
blood by sequential density ultracentrifugation i KBr solutions at 4°C 
as described elsewhere [13] and radiolabelled with Na ‘*‘I using iodine 
monochloride 1141. 
2.2. Caeruloplasmin preincubation 
Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; LDL, Caeruloplasmin was obtained from Calbiochem (Nottingham, UK). 
low-density lipoprotein; PBS, phosphate-buffered saline. It had an A,,,,IA,,, ratio of0.048 (this is a spectrophotometric indication 
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of the ratio of copper atoms to protein) which is consistent with an 
intact copper-protein complex [15,16] and ran largely as a single band 
on an SDS-polyacrylamide gel, with a molecular weight of approxi- 
mately 132,000 kDa. Caeruloplasmin (3 mg/ml) was preincubated at 
37°C in either a 50 mM sodium phosphate buffer (pH 5.c7.4) or a 50 
mM sodium acetate buffer (pH 4.5) for 24 h. It was then diluted 1 in 
100 to give a final concentration of 30 pg caeruloplasmin/ml in Ham’s 
F-10 medium specially formulated to be deficient in FeSO,, CuSO, and 
&SO, (Irvine Scientific, Santa Anna, USA). 
2.3. Modification of LDL by macrophages 
Resident mouse peritoneal macrophages were isolated by peritoneal 
lavaae of female Swiss T.O. mice as described elsewhere 1141. 12’1- 
labeced LDL (lOOpug protein/ml) was incubated in triplicate Githintact 
macrophages (1.25 x lo6 peritoneal cells/ml) or cell-free wells in tripli- 
cate with either 30 pg native caeruloplasmin/ml, 30 pg preincubated 
caeruloolasmin/ml or CuSO, (uo to 2 uM) for 18 h at 37°C in Ham’s 
F-10 medium specially formulated to be deficient in FeSO,, CuSO, and 
ZnSO,. 
2.4. Determination of oxidised LDL degradation by mouse peritoneal 
macrophages 
Modified or control ‘ZSI-labelled LDL was diluted to 1Opg protein/ml 
in DMEM containing 20% (v/v) foetal calf serum, 1Opg gentamicimml, 
lOpug streptomicin/ml, 10 I.U. penicillin/ml and 5 pg amphotericin B/ml 
(Gibco. Middlesex. UK). It was then incubated for 2G22 h with a 
second’set of macrophages (1 x lo6 mouse peritoneal cells/well) or cell- 
free wells with 1 ml per well. The radioactive noniodide, trichloroacetic 
acid-soluble degradation products released into the medium were meas- 
ured as described previously [13]. The degradation products in the 
cell-free wells were subtracted from those in the wells containing cells. 
The cells were washed in PBS containing Ca” and Mg’+, lysed in 0.2 
M NaOH as described elsewhere [14] and assayed for protein by a 
modified Lowry procedure [17]. 
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Fig. 1. The effect of increasing concentrations of CuSO, on macro- 
phage-mediated LDL modification. ‘251-labelled LDL (100 yg protein/ 
ml) was incubated for 18 h at 37°C with mouse peritoneal macrophages 
(1.25 x lo6 peritoneal cells/ml) or in cell-free wells in Ham’s F-10 me- 
dium specially formulated to be deficient in FeSO,, CuSO., and ZnSO,. 
Increasing concentrations of CuSO, were added from a stock 1 mM 
aqueous olution. The rate of degradation of the macrophage-modified 
LDL (solid histobars) and control LDL (hatched histobars) by a second 
set of mouse peritoneal macrophages was then determined. Each point 
is the mean f S.E.M. of three wells. 
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Fig. 2. The effect of preincubating caeruloplasmin at acidic pH in an 
acetate buffer on its ability to catalyse the modification of LDL by 
macrophages. Caeruloplasmin (3 mg/ml) was preincubated in a sodium 
acetate buffer, pH 4.5 or 7.0 for 24 h at 37°C. ‘251-labelled LDL (100 
pg protein/ml) was incubated for 18 h at 37’C with mouse peritoneal 
macrophages (1.25 x lo6 peritoneal cells/ml) or in cell-free wells in 
Ham’s F-10 medium specially formulated to be deficient in FeSO,, 
CuSO, and ZnSO,. Preincubated or native caeruloplasmin was added 
to the macrophages at a final concentration of 30 pug/ml. The rate of 
degradation of the macrophage-modified LDL (solid histobars) and 
control LDL (hatched histobars) by a second set of macrophages was 
then determined. Each point is the mean + S.E.M. of 3 wells. 
3. Results 
‘251-labelled LDL was incubated with mouse perito- 
neal macrophages in Ham’s F-10 medium deficient in 
iron, copper and zinc ions in the presence of either 
CuS04, native caeruloplasmin or caernloplasmin that 
had been preincubated at various pH values. The rate of 
degradation of these LDLs by a second set of mouse 
peritoneal macrophages was then determined. 
The effect of increasing concentrations of C&O, on 
LDL modification by macrophages is shown in Fig. 1. 
There was no apparent LDL modification in the absence 
of CuSO,, but a progressive increase in LDL modifica- 
tion by the macrophages was observed as the concentra- 
tion of CuSO, was increased. A concentration of 0.5 ,uM 
CuSO, resulted in the macrophages modifying the LDL 
so that it was degraded by a second set of macrophages 
around twice as fast as the control LDL. Increasing the 
CuSO, concentration to 1 PM resulted in the LDL being 
degraded by the macrophages around 3-4 times as fast 
as the control LDL. When 2 ,uM CuSO, was used, LDL 
incubated with macrophages and in cell-free wells was 
modified to a large and similar extent so that it was 
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Fig. 3. The effect of preincubating caeruloplasmin at acidic pH in a 
phosphate buffer on its ability to catalyse the modification of LDL by 
macrophages. Caeruloplasmin (3 mg/ml) was preincubated in a sodium 
phosphate buffer, pHs 5.0, 6.0, 7.0 and 7.4, and in a sodium acetate 
buffer pH 4.5 for 24 h at 37°C. ‘*SI-labelled LDL (100 fig protein/ml) 
was incubated for 18 h at 37°C with mouse peritoneal macrophages 
(1.25 x lo6 peritoneal cells/ml) or in cell-free wells in Ham’s F-10 me- 
dium specially formulated to be deficient in FeSO,, CuSO, and ZnSO,. 
Preincubated caeruloplasmin was added to the macrophages at a final 
concentration of 30 ,ug/ml. The rate of degradation of the macrophage- 
modified LDL (solid histobars) and control LDL (hatched histobars) 
by a second set of mouse peritoneal macrophages was then determined. 
Each point is the mean f S.E.M. of 3 wells. 
degraded by a second set of macrophages around 9-10 
times faster than unmodified LDL. 
The macrophages were apparently unable to modify 
the LDL in the presence of native caeruloplasmin (30 
yglml). Preincubation of caeruloplasmin in a sodium ac- 
etate buffer at pH 4.5, however, altered it in some way 
so that it became able to catalyse the macrophage-medi- 
ated modification of LDL, so that the LDL was de- 
graded much faster by a second set of macrophages (Fig. 
2). When the caeruloplasmin was preincubated in a so- 
dium acetate buffer at pH 7.0, it became able to catalyse 
the oxidation of LDL by macrophages but to a much 
lesser extent than after preincubation at pH 4.5. Caeru- 
loplasmin preincubated at pH 4.5, but not at pH 7.0, was 
able to modify LDL to a small extent in the absence of 
macrophages in this experiment, so that it was degraded 
faster than LDL incubated with native caeruloplasmin 
(Fig. 2), but this was not a consistent finding (Fig. 3). 
Caeruloplasmin was also preincubated in a sodium ace- 
tate buffer at pH 4.5 and in a sodium phosphate buffer 
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at pHs 5.0, 6.0, 7.0 and 7.4 (Fig. 3). After preincubation 
at pH 4.5 in the acetate buffer, the caeruloplasmin was 
able to catalyse the macrophage-mediated modification 
of LDL so that it was degraded by a second set of mac- 
rophages 7-8 times faster than control LDL. A progres- 
sive decrease in macrophage-mediated LDL modifica- 
tion was observed as the pH of the caeruloplasmin 
preincubation step was increased, so that at pH 7.4 the 
macrophage-modified LDL was degraded only about 
twice as fast as the control LDL. 
Caeruloplasmin was preincubated at pH 4.5 in a so- 
dium acetate buffer and added in increasing concentra- 
tions to mouse peritoneal macrophages and LDL (Fig. 
4). In the absence of caeruloplasmin, the macrophages 
were apparently unable to modify the LDL. A progres- 
sive increase in macrophage-mediated LDL modification 
was observed as the concentration of caeruloplasmin was 
increased. At a concentration of 30 &ml, the preincu- 
bated caeruloplasmin was able on this occasion to cat- 
alyse LDL modification by macrophages so that the 
LDL was degraded around 3 times faster than LDL 
incubated with macrophages in the absence of caeru- 
loplasmin. As the concentration of preincubated caeru- 
loplasmin was increased there was a progressive increase 
6 
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Fig. 4. The effect of increasing the concentration of preincubated caer- 
uloplasmin on the macrophage-mediated modification of LDL. Caeru- 
loplasmin (30 mg/ml) was preincubated in a sodium acetate buffer at 
pH 4.5 for 24 h at 37°C. ‘251-labelled LDL (100 pg protein/ml) was 
incubated for 18 h at 37°C with mouse peritoneal macrophages 
(1.25 x lo6 peritoneal cells/ml) or in cell-free wells in Ham’s F-10 me- 
dium specially formulated to be deficient in FeSO,, CuSO, and ZnSO,. 
Preincubated caeruloplasmin was added to the macrophages in increas- 
ing concentrations up to 300 pg/ml. The rate of degradation of the 
macrophage-modified LDL (solid histobars) and control LDL (hatched 
histobars) by a second set of mouse peritoneal macrophages was then 
determined. Each point is the mean + S.E.M. of 3 wells. 
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in the modification of LDL by macrophages o that at 
225 j&nl and over the LDL was degraded around 16 
times faster than LDL incubated with macrophages 
alone. The degradation of control LDL that had been 
incubated in cell-free wells was not increased until the 
caeruloplasmin concentration reached 90 pg/ml, when 
there was a small increase in the degradation of the 
control LDL. There was then a progressive increase in 
the degradation of control LDL as the concentration of 
caeruloplasmin was increased so that at a concentration 
of 300 @ml the control LDL was degraded 7-8 times 
faster than control LDL that had been incubated in the 
absence of caeruloplasmin. In all cases when preincu- 
bated caeruloplasmin was present, however, LDL was 
modified faster when macrophages were present than 
when they were absent. 
4. Discussion 
The mechanism by which LDL becomes oxidised to an 
atherogenic form in the arterial wall is as yet unknown, 
but seems likely to be dependent on the presence of 
catalytically active transition metal ions. There is some 
evidence that elevated plasma copper levels are associ- 
ated with coronary artery disease [7,9-l 11. In addition, 
canine aortas contain around 6 pmol copper atoms/kg 
wet issue [18] and human atherosclerotic plaques have 
been found to contain 0.11 g of caeruloplasmin/kg dry 
tissue (equivilant o 5.5 pmol copper atoms/kg dry tissue) 
[ 191. Gruel taken from human advanced atherosclerotic 
lesions has been shown to contain up to 28 PM catalyti- 
cally active copper. ions [20]. 
We have shown here that low levels of CuSO, can 
catalyse the macrophage-mediated modification of LDL 
to increase its rate of degradation by a second set of 
macrophages. The macrophages were apparently unable, 
however, to modify the LDL in the presence of native 
caeruloplasmin. This suggests that the copper atoms are 
tightly bound in caeruloplasmin and are unable to redox 
cycle in a way that can catalyse LDL oxidation. When 
caeruloplasmin was preincubated at acidic pH prior to 
incubation with LDL and macrophages, however, it be- 
came able to catalyse the modification of LDL by macro- 
phages. This effect was found to be pH dependent so that 
as the pH was lowered, the catalytic ability of the caeru- 
loplasmin was increased progressively. This may possi- 
bly represent sequential release or activation of the dif- 
ferent types of copper atoms in caeruloplasmin; type-1 
copper being more labile than the others [3] may be 
released or activated at mildly acidic pH whereas the 
more stable types of copper may be released or activated 
only at more acidic pH values. Preincubation of caeru- 
loplasmin at pH 4.5 did not result in any apparent degra- 
dation of the protein as estimated by SDS-poly- 
acrylamide gel electrophoresis (data not shown). 
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There appears to be a fairly large difference between 
preincubation at pH 4.5 and 5.0 on the catalytic abilities 
of caeruloplasmin (Fig. 3). This possibly reflects differ- 
ences between phosphate and acetate buffers. It was not 
possible to find a buffer system that had a pH range of 
4.5-7.4, was not toxic to macrophages, did not chelate 
copper ions and did not contain components possessing 
antioxidant properties, hence two systems were used to 
create the pH range desired. It is possible that in a phos- 
phate buffer at acidic pH, some of the copper ions re- 
leased into the medium were forming inactive complexes 
with phosphate thereby reducing the number of active 
copper ions able to catalyse the modification of LDL and 
hence limiting the overall degree of LDL modification. 
It was observed that adding saturated copper sulphate 
to these phosphate buffers resulted in visibly increasing 
precipitation as the pH of the buffer was lowered. This 
did not occur in the acetate buffer. This possibly explains 
the large difference between the extents of LDL oxida- 
tion at pH 4.5 (acetate) and pH 5.0 (phosphate) shown 
in Fig. 3. 
The normal plasma concentration of caeruloplasmin 
is about 300 ,@ml[2]. The concentration of caeruloplas- 
min used throughout these experiments was 30 &ml, 
which is just 10% of the normal plasma level. This con- 
centration of caeruloplasmin would contain 1.5 PM cop- 
per atoms (assuming an average of 6.5 copper atoms per 
molecule of caeruloplasmin based on its A6,dA280 ratio) 
which is more than sufficient in terms of ‘free’ copper 
ions to catalyse the modification of LDL in the presence 
of macrophages in this system (Fig. 1). Increasing the 
concentration of caeruloplasmin that had been preincu- 
bated at acidic pH resulted in a progressive increase of 
both macrophage-mediated and cell-free LDL modifica- 
tion, so that at a concentration of 300 ,ug caeruloplasmin/ 
ml (the normal plasma concentration) both macrophage- 
incubated and cell-free LDL were extensively modified, 
probably to a maximal extent in the case of macrophage- 
incubated LDL since the degree of degradation of the 
macrophage-modified LDL appeared to have plateaued. 
Using the figure of 0.11 g of caeruloplasmin/kg dry tissue 
for human atherosclerotic plaques [19], it can be calcu- 
lated that the extracellular fluid in these lesions should 
contain a sufficient concentration of caeruloplasmin to 
cause considerable LDL oxidation if the copper were to 
become catalytically active. 
Caeruloplasmin at physiological concentrations or 
below can release or express ufficient catalytically active 
copper ions at moderately acidic pH to catalyse the mod- 
ification of LDL to an atherogenic form in the presence 
of macrophages. But are these acidic conditions likely to 
occur within an atherosclerotic lesion? The media of 
large arteries is paradoxically, one of the most poorly 
perfused tissues in the human body and hence experi- 
ences a low oxygen tension [21] and is therefore partially 
ischaemic which may result in a local lactic acidosis and 
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a depression of pH. In support of this, the extracellular 
pH at the centre of a necrosing tumour in a hypergly- 
caemic animal, also partially ischaemic, has been meas- 
ured to be as low as 5.2 [22]. In addition, atherosclerosis 
is now often described as a chronic inflammatory dis- 
ease, and by analogy to other inflammatory sites [23], the 
pH could be expected to fall below pH 7.4. Macrophages 
in atherosclerotic plaques have many of the characteris- 
tics of activated macrophages [24] and the pH measured 
near an activated macrophage can fall to as low as 3.6 
[25]. Hence, it is possible for the pH of both early and 
advanced atherosclerotic plaques, particularly in the vi- 
cinity of macrophages, to fall below pH 7.4, although 
there is as yet no evidence that this occurs. 
There is evidence that high serum copper or caeru- 
loplasmin levels are associated with coronary artery dis- 
ease. The local modification of LDL to an atherogenic 
form within the arterial wall by macrophages and other 
cells may possibly be mediated, at least in part, by copper 
ions released from caeruloplasmin at the low pH values 
that may be present within atherosclerotic lesions. As 
well as releasing copper from caeruloplasmin (and possi- 
bly iron from transferrin [26,27]), an extracellular acidic 
pH has also been shown to increase the rate of oxidation 
of LDL by macrophages [28]. 
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